Development of new strategy for fracture treatment by human mature osteoblast
| Project/Area Number |
15H06188
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Orthopaedic surgery
|
|---|
| Research Institution | Tokyo Medical and Dental University |
|---|
Principal Investigator |
Fujita Koji 東京医科歯科大学, 大学院医歯学総合研究科, 助教 (80451970)
|
|---|
| Project Period (FY) |
2015-08-28 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 成熟骨芽細胞 / 骨粗鬆症 / ヒト成熟骨芽細胞 / 骨折治療 / 骨芽細胞 / 骨形成 |
|---|
| Outline of Final Research Achievements |
The aim of our research is to develop a new strategy of fracture healing by using human mature osteoblast, and in this project we finished a couple of steps. First, we modified the protocol of osteoblast isolation by using new collagenase. With this, the efficacy of isolation increased 2-3 times. Second, we analyzed the effect of donors' disease on gene expression of osteoblast. As a result, we found diabetes changed the gene expression siginificantly. Finally, we started the experiments of transplant of human mature osteoblast to rat model to evaluate the bone formation ability.
|
Report
(3 results)
Research Products
(5 results)
